About this app
What is Chambers Of Ancients?
RubyPlay’s broader licensing footprint and distribution also give Splash Tech access to operators and markets it could not have pursued efficiently alone.
“Because you’re a small business, you need to pick your battles,” Wilson says. “I can’t go and get 10 licences this year. It’s just unrealistic. It would require so much work that it would distract us. Now we have that ability through our relationship with RubyPlay, and we are grabbing that opportunity with both hands.”
There is also a natural product opportunity. Splash Tech has traditionally been weighted towards sports within free-to-play, while RubyPlay brings a substantial casino ecosystem. For Wilson, the agreement creates a chance for Splash Tech to bring its distinctive engagement thinking into the RubyPlay world, planting a seed for future products that combine Splash Tech’s free-to-play and jackpot expertise with RubyPlay’s content ecosystem, market knowledge and distribution reach.
What is Chambers Of Ancients?
Spotlight Sports Group has expanded into the games vertical for the first time through a collaboration with the supplier Engage Games.
Announced on Thursday, the strategic partnership will grant Spotlight’s network of global sportsbook operators access to Engage Games’ bespoke games, each built collaboratively with Spotlight’s partners.
It marks Spotlight’s first expansion into gaming, combining the company’s global product and content distribution with Engage Games’ platform and track record in free-to-play and pay-to-play games.
What is Chambers Of Ancients?
The MLB and NHL futures contracts could be deployed by big-money bettors as hedges on various team exposures over the course of those leagues’ seasons.
As for the regulatory outlooks for the ETFs, the SEC hasn’t publicly commented on the NHL funds’ fates and it’s too early to tell what will come of the MLB filings, but there are hundreds of futures-based ETFs on the market today.
That may be a sign that pro sports futures ETFs could avoid the “novel” label that’s been a hindrance in bringing other ETFs to market.
